Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis
- PMID: 34026125
- PMCID: PMC8117815
- DOI: 10.1002/ccr3.3925
Statin-associated necrotizing autoimmune myopathy with concurrent myasthenia gravis
Abstract
Statin treatment has been associated with necrotizing autoimmune myopathy and has been linked to myasthenia gravis. We present an unprecedented clinical challenge with both disorders occurring in a patient treated with statins few months earlier.
Keywords: autoimmune disease; myasthenia gravis; necrotizing autoimmune myopathy; statins.
© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
None of the authors has potential conflicts of interest to be disclosed.
Figures
References
-
- Mammen AL. Statin‐Associated Autoimmune Myopathy. N Engl J Med. 2016;374:664‐669. - PubMed
-
- Du Souich P, Roederer G, Dufour B. Myotoxicity of statins: Mechanism of action. Pharmacol Ther. 2017;175:1‐16. - PubMed
-
- Khalid R, Ibad A, Thompson PD. Statins and myasthenia gravis. Muscle Nerve. 2016;54:509. - PubMed
-
- Yongchairat K, Tanboon J, Waisayarat J, et al. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case‐control study. Clin Rheumatol. 2019;38:3459‐3469. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
